SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 23rd, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 23rd, 2013 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of December 28, 2012, by and among ARATANA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the investors set forth on the Schedule of Investors attached hereto as Exhibit A (each, an “Investor” and collectively, the “Investors”).
SECOND AMENDED AND RESTATED| INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • April 30th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 30th, 2013 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of December 28, 2012, by and among ARATANA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the investors set forth on the Schedule of Investors attached hereto as Exhibit A (each, an “Investor” and collectively, the “Investors”).
SECOND AMENDED AND RESTATED| INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • March 20th, 2013 • Aratana Therapeutics, Inc. • Delaware
Contract Type FiledMarch 20th, 2013 Company JurisdictionTHIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of December 28, 2012, by and among ARATANA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the investors set forth on the Schedule of Investors attached hereto as Exhibit A (each, an “Investor” and collectively, the “Investors”).